Pharmacokinetics and Pharmacodynamics of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.50, Iss.4, 2011-04, pp. : 215-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and pharmacodynamics of mepolizumab, an anti–interleukin 5 monoclonal antibody, in healthy Japanese male subjects

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 102-108

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mepolizumab: 240563, Anti-IL-5 Monoclonal Antibody - GlaxoSmithKline, Anti-Interleukin-5 Monoclonal Antibody - GlaxoSmithKline, SB 240563

By Adis International Limited

Drugs in R&D, Vol. 9, Iss. 2, 2008-01 ,pp. : 125-130

Adis International

Access to resources Recommend Favorite

Anti-Interleukin-6 Receptor Antibody Therapy in Rheumatic Diseases

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 373-381

Bentham Science Publishers

Access to resources Recommend Favorite

Accumulation of Antibody-Target Complexes and the Pharmacodynamics of Clotting after Single Intravenous Administration of Humanized Anti-Factor IX Monoclonal Antibody to Rats

By Davis Charles B. Tobia Leeann P. Kwok Deborah C. Oishi Christine M. Kheterpal Neil Hepburn Timothy W. Benincosa Lisa J. Chow Fung-Sing Jusko William J.

Drug Delivery, Vol. 6, Iss. 3, 1999-07 ,pp. : 171-179

Informa Healthcare

Access to resources Recommend Favorite

Eculizumab: 5G1.1, h5G1.1, Long-Acting Anti-C5 Monoclonal Antibody 5G1-1, Long-Acting Anti-C5 Monoclonal Antibody 5G1.1

By Adis International Limited

Drugs in R&D, Vol. 8, Iss. 1, 2007-01 ,pp. : 61-68

Adis International

Access to resources Recommend Favorite